Both in Pharmaceuticals
Neurogene vs DiaMedica Therapeutics
Over the past year NGNE returned −13.6% and DMAC returned +58.8%; their daily moves had a correlation of 0.26.
NGNE −13.6% DMAC +58.8%Growth of $1, one year, split-adjusted
| Metric | NGNE | DMAC |
|---|---|---|
| Price | $26.85 | $10.80 |
| Market cap | $537.3M | $582.4M |
| Today | +0.67% | +8.00% |
| 1 month | +5.5% | +32.8% |
| 6 months | −17.0% | +65.6% |
| Year to date | +30.3% | +35.7% |
| 1 year | −13.6% | +58.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $225.4M | $43.5M |
| Dividend yield | — | — |
| Volatility (60d) | 76.3% | 56.4% |
| Short % of float | 39.6% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).